858 Therapeutics
858 Therapeutics develops small molecule drugs targeting oncology and immunology.
1
Funding Rounds
$60.0m
Money raised
Overview
858 Therapeutics develops small molecule drugs targeting oncology and immunology.
- Website:
- Business model: B2B
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Gr****** Ba** | - | - | |
| Je***** St****** |
|
- | |
| Ji* Ve** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Al* Be******* | - | - | |
| Ca*** Ri***** | - | - | - |
| Cl*** Oz*** | - | - |
Funding series
Funding Series Analysis
The company 858 Therapeutics has raised a total of $60m in funding over 1 rounds.
Key Insights:
- 858 Therapeutics Series A round, September 2021: $60m
858 Therapeutics Series A round, September 2021
$60m
Industries
858 Therapeutics is active in the following industries:
- Biotechnology
- Pharmaceutical industry
- Health technology